ClinicalTrials.gov
ClinicalTrials.gov Menu

Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention. (FOCUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01321255
Recruitment Status : Completed
First Posted : March 23, 2011
Last Update Posted : July 15, 2014
Sponsor:
Collaborators:
Mario Negri Institute for Pharmacological Research
Rusculleda Foundation Instituto DAMIC
Fundacion Clinic per a la Recerca Biomédica
ARTTIC International Management Services
Federación Argentina de Cardiología FAC
World Health Organization
Instituto de Salud Carlos III
Ferrer Internacional S.A.
Information provided by (Responsible Party):
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2014
  Actual Study Completion Date : June 2014
Publications:
World Health Organization. Price, availability and affordability. An international comparison of chronic disease medicines. Background report prepared for the WHO Plannig Meeting on the Global Initiative for Treatment of Chronic Diseases, Cairo, December 2005
European Cardiovascular Disease Statistics. British Heart Foundation and European Heart Network. 2005
European Health Heart Charter. Available at www.heartcharter.eu
kaplan W. LR. Priority medicines for Europe and the World; 2004 November.
Doval HCT, C.D. Prevención secundaria de las enfermedades cardiovasculares. In: Evidencias en Cardiología. Buenos Aires: GEDIC; 2008.
Trust WW. Second World Health Organization & Wellcome Trust Workshop. In: Secondary Prevention of Cardiovascular Disease in Low & Middle Income Countries - Building the Evidence Base on Secondary Prevention of CVD. 2007 6-8 June; London; 2007
Pharma 2020: the vision. Which path will you take? (Accessed at http://www.pwc.com/pharma.)
Bosworth HB. Medication treatment adherence. Chapter 6, 147-94. In: Bosworth H, Oddone, E., Weinberger, M., ed. In:
World Bank Report: Public Policy and the Challenge of Chronic Noncommunicable Diseases. 2007. (Accessed at http://siteresources.worldbank.org/INTPH/Resources/PublicPolicyandNCDsWorldBank2007FullReport.pdf.)
Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychology Measurements 1977;1.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):